Gerald Batist
机构: Professor,McGill University
每年引用次数
引用次数
引用: 23,466
H-指数: 71
I10-指数 : 246
出版物: 555
The influence of dietary whey protein on tissue glutathione and the diseases of aging.
G Batist , F Gervais , P Gold , G Bounous
Clinical and Investigative Medicine 12 ( 6) 343 -349
182
1989
Characterization of 5-oxo-L-prolinase in normal and tumor tissues of humans and rats: a potential new target for biochemical modulation of glutathione.
G Batist , R L Schecter , L C Alpert , X Chen
Clinical Cancer Research 4 ( 1) 131 -138
19
1998
In vivo reversal of doxorubicin resistance by a new tiapamil analog Ro11-2933.
G Batist , S Lehnert , R L Schecter , Y M Rustum
Journal of Pharmacology and Experimental Therapeutics 264 ( 3) 1299 -1304
17
1993
Efficacy and toxicity of ifosfamide stereoisomers in an in vivo rat mammary carcinoma model
G Batist , T Wang , I W Wainer , C P Granvil
Cancer Research 54 ( 16) 4393 -4397
20
1994
"Ifosfamide: should the honeymoon be over?": a two-dimensional question for a three-dimensional problem.
G Batist , I W Wainer , J Ducharme
Journal of Clinical Oncology 13 ( 7) 1824 -1826
2
1995
Mechanisms of resistance to (2-chloroethyl)-3-sarcosinamide-1-nitrosourea (SarCNU) in sensitive and resistant human glioma cells.
D Kopriva , V Skalski , P Gros , G Batist
Molecular Pharmacology 38 ( 3) 299 -305
8
1990
Enhanced DNA cross-link removal: the apparent mechanism of resistance in a clinically relevant melphalan-resistant human breast cancer cell line.
D Greene , J M Demuys , S Torres-Garcia , M Rochon
Molecular Pharmacology 36 ( 2) 224 -230
42
1989
Regulation of the gap junction connexin 43 gene by androgens in the prostate.
HT Huynh , L Alpert , DW Laird , G Batist
Journal of Molecular Endocrinology 26 ( 1) 1 -10
22
2001
Phase I and pharmacokinetic trial of paclitaxel in patients with hepatic dysfunction: Cancer and Leukemia Group B 9264.
A P Venook , M J Egorin , G L Rosner , T D Brown
Journal of Clinical Oncology 16 ( 5) 1811 -1819
113
1998
Phase I and pharmacologic study of continuous infusion topotecan in combination with cisplatin in patients with advanced cancer: a Cancer and LeukemiaGroup B study.
R C Lilenbaum , A A Miller , G Batist , S Bernard
Journal of Clinical Oncology 16 ( 10) 3302 -3309
19
1998
Synthesis and cytotoxic evaluation of some styryl ketones and related compounds
JR Dimmock , P Kumar , JW Quail , U Pugazhenthi
European Journal of Medicinal Chemistry 30 ( 3) 209 -217
15
1995
Etoposide (VP-16) and cisplatin in previously treated small-cell lung cancer: clinical trial and in vitro correlates.
G Batist , D N Carney , K H Cowan , S R Veach
Journal of Clinical Oncology 4 ( 6) 982 -986
35
1986
Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells.
G Batist , A Tulpule , B K Sinha , A G Katki
Journal of Biological Chemistry 261 ( 33) 15544 -15549
677
1986
Transcriptional repression of TFIIH subunits XPB/ERCC3 and XPD/ERCC2 by hepatitis B virus X protein
I Jaitovich Groisman , R Koshy , G Batist , N Foutouhi Ardakani
Biochemistry and Cell Biology 75 ( 4) 469
1997
Magnetotactic bacteria penetration into multicellular tumor spheroids for targeted therapy
N Mokrani , O Felfoul , Fatemeh Afkhami Zarreh , M Mohammadi
international conference of the ieee engineering in medicine and biology society 2010 4371 -4374
26
2010
Volume 34-No. 12-December 2023
Seth A Wander , IA McNeish , BJ Monk , A D’Souza
Oncology 30 v820 -v820
2019
Serial Monitoring of Plasma ctDNA in Metastatic Colorectal Cancer Patients Detects Changes in Key Mutations and Disease Progression Using the FOLLOW IT Assay from the Exactis Trial (NCT00984048)
MK McConechy , S McNamara , M Couetoux du Tertre , K Gambaro
JOURNAL OF MOLECULAR DIAGNOSTICS 22 ( 5) S7 -S7
2020
COVID-19 and Cancer Consortium
NM Kuderer , TK Choueiri , DP Shah , Y Shyr
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet 395 ( 10241) 1907 -1918
55
2020
338. Comparing characteristics and survival outcomes of adolescent and young adults to mature patients with colorectal cancer
YS Rho , M Gilabert , K Polom , A Aladashvili
European Journal of Surgical Oncology 42 ( 9) S152 -S152
2016
A dose escalation phase I study of c-myc antisense in combination with cisplatin in the treatment of solid tumors and lymphomas.
K Gelmon , G Batist , K Chi , V Sandor
CLINICAL CANCER RESEARCH 7 ( 11) 3814S -3815S
5
2001